Science

The Rising Trend of U.S. Researcher Emigration

A growing climate of uncertainty regarding research funding and termination increasingly pressures many American researchers to seek work abroad.

Reading Time: 3 minutes

Cover Image
By Alina Dong

The ongoing implementation of the Trump administration’s “gold standard science” (GGS) executive order since May 2025 has led to attempts to alter federal funding, creating a period of uncertainty. For instance, a fiscal budget proposal from the president's administration aimed to significantly reduce the budget allocated to the National Institute on Aging in 2026. If passed, the policy would have cut the research department’s funding by 40 percent, impacting all types of projects and educational programs centered on cancer, heart disease, and diabetes studies. Fortunately, Congress and lawmakers firmly rejected the proposal in February 2026, but the Trump administration’s attempt to further constrain research budgets ultimately left many American researchers anxious.

In recent Boston National Public Radio WBUR coverage, American biochemist and molecular biologist Philip Zamore announced his plans to move to Canada for research, leaving his chair position at UMass Chan Medical School. After exploring numerous opportunities abroad, he decided to relocate his research laboratory along with his team to McGill University in Montreal. His decision was not sudden, but was instead heavily influenced by ongoing uncertainty surrounding federal grants and funding for research projects, a rising concern that could affect the state of scientific research in the United States.

As this distribution of federal funding for both government and private scientific institutions remains vulnerable to change, cases like Zamore's may exemplify the possibility of a rising trend of American researcher emigration. Many individuals and teams consider leaving to pursue research abroad, with a recent New York Times article reporting that 48 researchers from highly regarded universities such as MIT and Harvard had been recruited by Canada. In response, foreign research institutions from Europe and Asia are taking advantage of the current circumstances. As a result, affected American researchers are constantly poached by competing international programs such as Choose France for Science and the ATRAE program from Spain. These foreign initiatives promise financial security, full support, and scientific freedom that have attracted many American researchers, who bring with them major projects and experimental findings.

As concerns of research suspension circulate among recent graduate students and younger researchers, perception of steady research employment in the United States has gradually become more negative. In an interview on the Pittsburgh News Station WESA, infectiologist Jason Walsman described his decision to migrate to China with his family to continue his research at Duke Kunshan University in Shanghai. For years, he and his family had looked for stable job opportunities around Pittsburgh, but luck had simply run out. The National Science Foundation (NSF) discontinued grants for Walsman’s research, forcing him to look for and accept positions abroad. Furthermore, the new NSF policy asserted the need to move toward more restrictive grants and funding, where projects should align with the interests of the organization besides being based on scientific merits. However, the organization had also publicly announced that it is looking forward to providing reinforced support for recent scientists and individual graduates amidst the prevalence of university research. 

While the president's administration’s GGS executive order continues to be executed, many agencies such as the U.S. Environmental Protection Agency (EPA) have remained firm in upholding the GGS policy of better research transparency and reproducibility. The EPA has recently resumed the task of reducing mammalian animal testing nationwide since July 2026, which was previously postponed during the Biden administration, leading to a collaborative initiative with the National Institutes of Health. This campaign has further ensured the development and regulation of alternatives to animal testing, illuminating an optimistic view on the year-old GGS decree. 

The Office of Science and Technology Policy, however, has recently released a report called “A New Golden Age” that provides a more extensive framework for future administrative procedures toward American science and research studies. The report claimed that government science funding systems and research institutions have become too inefficient and time-consuming, especially in an era of widespread AI technology and private research and development sectors. It proposes to transform the nation’s current scientific system to a model that accentuates AI, quantum development, and integration. This shift of priority away from traditional academic research and long-standing studies may further pose challenges for many university research institutions. 

Increasing involvement of politics in science by the Trump administration has certainly caused noticeable effects on the scientific community. Government officials have started to have a more decisive role in funding research projects, leading to unpredictability. As the midterm elections come closer, the administration may lose its control over scientific policies, possibly creating more autonomy over the distribution of federal funding. While expanding government aid could remedy these ongoing issues, the acceleration of AI research could possibly further widen financial gaps between industries and traditional research institutions. As concerns for U.S. researcher emigration become more apparent, the possibility of missed progress and discoveries becomes wider than ever.